Flexible Stenting Solutions (FSS; Eatontown, New Jersey) said the first two patients enrolled in its OPEN clinical trial have received treatment. The trial, which is both prospective and single-arm, will enroll up to 227 patients at as many as 40 clinical sites. (Medical Device Daily)
Read More
